ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO167

Vitamin K-Dependent Proteins After Kidney Transplantation: Results from a Prospective Study

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical

Authors

  • Fusaro, Maria, National Research Council (CNR) e Institute of Clinical Physiology (IFC), Pisa, Italy
  • Khairallah, Pascale, Columbia University Medical Center, New York, New York, United States
  • Aghi, Andrea, Nephrology Unit, University of Padua, Padova, Italy
  • Plebani, Mario, Laboratory Medicine Unit, Department of Medicine, University of Padova, Padova, Italy
  • Zaninotto, Martina, University Hospital, Padova, Italy
  • Cosma, Chiara, University Hospital, Padova, Italy
  • Aponte Farias, Maria A., Columbia University Medical Center, New York, New York, United States
  • Cortez, Natalia Erika, University of California, Davis, Davis, California, United States
  • Tripepi, Giovanni, IFC-CNR, Calabria, Italy
  • Nickolas, Tom, Columbia University Medical Center, New York, New York, United States
Background

Two Vitamin K-dependent proteins (VDKPs) link bone and vasculature in CKD-MBD: Bone Gla Protein (BGP) and Matrix Gla Protein (MGP). In ESKD, Vitamin K deficiency is highly prevalent and leads to increased levels of inactive VKDPs (undercaboxylated(uc) BGP and dephosphorylated(dp)-uc MGP), which are linked to greater risk of fractures and severity of vascular calcification. We hypothesized that kidney transplantation (KT) would improve Vitamin K status and lower levels of inactive VKDPs.

Methods

Between 2014-2017, we conducted a study in 34 patients to assess changes in VKDPs during the 1st year of KT. In a specialized lab we determined VKDPs pre- and 1-year post-KT: total BGP, uc BGP, total MGP, and dp-uc MGP. We determined the prevalence of Vitamin K deficiency based on levels of uc-BGP and dp-uc MGP

Results

Our cohort had a mean+/-SD age of 48+/-14 years, 32% were female and 97% were Caucasian. 1 year post-KT, there was a decrease in the levels of all VKDPs and the prevalence of Vitamin K deficiency(Table). Patients with greatest severity of Vitamin K deficiency pre-KT had the largest decreases of inactive VDKPs post-KT (Figure).

Conclusion

KT was associated with improvement in Vitamin K status as manifested by decreased levels of inactive VKDPs. These are the first prospective data on VKDPs in CKD patients pre- and post-KT. Studies are needed to assess the impact of improvement in VKDP status after KT on CKD-MBD outcomes.

VKDPs pre- and post-KT
VariablePre-KTPost-KTP-Value
uc-BGP ng/mL (median; IQR)8.56 (5.45, 9.55)3.41 (1.24, 4.80)< 0.001
Vitamin K deficient by uc-BGP – n (%)
(Cut-Off: uc-BGP>=4.5 ng/ml) *
26 (76.5%)11 (32.4%)<0.001
BGP ng/mL (median; IQR)132 (79.85, 279.5)22.55 (18.85, 30.6)<0.001
MGP nmol/L (median; IQR)29.19 (26.67, 32.30)20.15 (14.68, 23.23)<0.001
dp-ucMGP pmol/L (median; IQR)910.5 (653.3, 1396.5)637 (517, 777.5)< 0.001
Vitamin K deficient by dp-ucMGP- n (%)
(Cut-Off: dp-uc MGP>500 pmol/L)
33 (97.1%)27 (79.4%)0.012

*(Kuwabara et al. Osteoporos Int 2009)

Changes in circulating dp-ucMGP levels in relation to baseline values

Funding

  • Private Foundation Support